JP2000500746A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000500746A5 JP2000500746A5 JP1997518546A JP51854697A JP2000500746A5 JP 2000500746 A5 JP2000500746 A5 JP 2000500746A5 JP 1997518546 A JP1997518546 A JP 1997518546A JP 51854697 A JP51854697 A JP 51854697A JP 2000500746 A5 JP2000500746 A5 JP 2000500746A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9523379.7A GB9523379D0 (en) | 1995-11-16 | 1995-11-16 | Compound and method |
| GB9523379.7 | 1995-11-16 | ||
| GBGB9525704.4A GB9525704D0 (en) | 1995-12-15 | 1995-12-15 | Ligand and screening method |
| GB9525704.4 | 1995-12-15 | ||
| PCT/EP1996/004810 WO1997018303A1 (en) | 1995-11-16 | 1996-11-05 | Rac-proteine kinase as therapeutic agent or in diagnostics |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000500746A JP2000500746A (ja) | 2000-01-25 |
| JP2000500746A5 true JP2000500746A5 (ja) | 2004-10-14 |
| JP4173544B2 JP4173544B2 (ja) | 2008-10-29 |
Family
ID=26308124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51854697A Expired - Lifetime JP4173544B2 (ja) | 1995-11-16 | 1996-11-05 | 治療剤としての、または診断におけるｒａｃ−プロテインキナーゼ |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0862622B1 (ja) |
| JP (1) | JP4173544B2 (ja) |
| AT (1) | ATE274053T1 (ja) |
| AU (1) | AU7564396A (ja) |
| DE (1) | DE69633186T2 (ja) |
| DK (1) | DK0862622T3 (ja) |
| ES (1) | ES2227614T3 (ja) |
| PT (1) | PT862622E (ja) |
| WO (1) | WO1997018303A1 (ja) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9525703D0 (en) * | 1995-12-15 | 1996-02-14 | Ciba Geigy Ag | Screening method |
| US6057117A (en) * | 1996-04-04 | 2000-05-02 | Chiron Corporation | Identification and use of selective inhibitors of glycogen synthase kinase 3 |
| CA2214841A1 (en) * | 1997-10-31 | 1999-04-30 | Lisa Mckerracher | Rho antagonists and their use to block inhibition of neurite outgrowth |
| SE9801530D0 (sv) * | 1998-04-30 | 1998-04-30 | Pharmacia & Upjohn Ab | Method for screening |
| US6555732B1 (en) | 1998-09-14 | 2003-04-29 | Pioneer Hi-Bred International, Inc. | Rac-like genes and methods of use |
| DE69941877D1 (de) * | 1998-10-16 | 2010-02-11 | Otsuka Pharma Co Ltd | Neovaskular-spezifische peptide |
| US7169783B2 (en) | 1998-11-02 | 2007-01-30 | Universite De Montreal | (+)-Trans-4-(1-aminoethyl)-1-(4-pyridycarbamoyl)-cyclohexane and method for promoting neural growth in the central nervous system and in a patient at a site of neuronal lesion |
| GB9828375D0 (en) * | 1998-12-22 | 1999-02-17 | Janssen Pharmaceutica Nv | Human akt-3 |
| WO2000050452A1 (en) * | 1999-02-26 | 2000-08-31 | University College London | Mutants of rac protein |
| CA2343074C (en) * | 1999-03-19 | 2010-09-21 | Aventis Pharmaceuticals Products Inc. | Akt nucleic acids, polypeptides, and uses thereof |
| US6881555B2 (en) | 1999-03-19 | 2005-04-19 | Aventis Pharmaceuticals Inc. | AKT nucleic acids, polypeptides, and uses thereof |
| WO2001092499A1 (en) * | 2000-05-30 | 2001-12-06 | Moelling Karin | NUCLEIC ACID MOLECULES ENCODING A PROTEIN INTERACTING WITH Ser/Thr KINASE Akt |
| US6689807B1 (en) | 2000-06-08 | 2004-02-10 | Caritas St. Elizabeth's Medical Center Of Boston, Inc. | HMG CoA reductase inhibitors for promoting angiogenesis |
| GB0014185D0 (en) * | 2000-06-09 | 2000-08-02 | Novartis Res Found | Compound and method |
| ATE503483T1 (de) | 2002-10-30 | 2011-04-15 | Merck Sharp & Dohme | Hemmer der akt aktivität |
| GB0227562D0 (en) | 2002-11-26 | 2002-12-31 | Novartis Forschungsstiftung | Phorphorylated NDR Kinase |
| WO2006033942A2 (en) * | 2004-09-17 | 2006-03-30 | Exelixis, Inc | Pik4ca as modifier of the rac pathway and methods of use |
| NZ716765A (en) * | 2013-11-01 | 2020-02-28 | Pitney Pharmaceuticals Pty Ltd | Pharmaceutical combinations for the treatment of cancer |
-
1996
- 1996-11-05 DE DE69633186T patent/DE69633186T2/de not_active Expired - Lifetime
- 1996-11-05 AU AU75643/96A patent/AU7564396A/en not_active Abandoned
- 1996-11-05 DK DK96938081T patent/DK0862622T3/da active
- 1996-11-05 WO PCT/EP1996/004810 patent/WO1997018303A1/en active IP Right Grant
- 1996-11-05 ES ES96938081T patent/ES2227614T3/es not_active Expired - Lifetime
- 1996-11-05 JP JP51854697A patent/JP4173544B2/ja not_active Expired - Lifetime
- 1996-11-05 PT PT96938081T patent/PT862622E/pt unknown
- 1996-11-05 AT AT96938081T patent/ATE274053T1/de active
- 1996-11-05 EP EP96938081A patent/EP0862622B1/en not_active Expired - Lifetime